J. Nachman, H. Sather, M. Sensel, P. Gaynon, D. Arthur et al., Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy, New England Journal of Medicine, vol.338, issue.23, pp.1663-71, 1998.
DOI : 10.1056/NEJM199806043382304

M. Amylon, J. Shuster, J. Pullen, C. Berard, M. Link et al., Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study, Leukemia, vol.13, issue.3, pp.335-377, 1999.
DOI : 10.1038/sj.leu.2401310

C. Pui, J. Sandlund, D. Pei, D. Campana, G. Rivera et al., Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital, Blood, vol.104, issue.9, pp.2690-2696, 2004.
DOI : 10.1182/blood-2004-04-1616

A. Schrauder, A. Reiter, H. Gadner, D. Niethammer, T. Klingebiel et al., Superiority of Allogeneic Hematopoietic Stem-Cell Transplantation Compared With Chemotherapy Alone in High-Risk Childhood T-Cell Acute Lymphoblastic Leukemia: Results From ALL-BFM 90 and 95, Journal of Clinical Oncology, vol.24, issue.36, pp.5742-5751, 2006.
DOI : 10.1200/JCO.2006.06.2679

J. Pullen, J. Shuster, M. Link, M. Borowitz, M. Amylon et al., Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study, Leukemia, vol.13, issue.11, pp.1696-707, 1999.
DOI : 10.1038/sj.leu.2401555

A. Carroll, W. Crist, M. Link, M. Amylon, D. Pullen et al., The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study, Blood, vol.76, pp.1220-1224, 1990.

E. Mcguire, R. Hockett, K. Pollock, M. Bartholdi, O. Brien et al., The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein., Molecular and Cellular Biology, vol.9, issue.5, pp.2124-2156, 1989.
DOI : 10.1128/MCB.9.5.2124

B. Royer-pokora, U. Loos, and W. Ludwig, TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute Tcell leukaemia with the t(11;14) (p13;q11), Oncogene, vol.6, pp.1887-93, 1991.

Y. Xia, L. Brown, C. Yang, J. Tsan, M. Siciliano et al., TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia., Proceedings of the National Academy of Sciences, vol.88, issue.24, pp.11416-11436, 1991.
DOI : 10.1073/pnas.88.24.11416

J. Mellentin, S. Smith, and M. Cleary, lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif, Cell, vol.58, issue.1, pp.77-83, 1989.
DOI : 10.1016/0092-8674(89)90404-2

F. Speleman, B. Cauwelier, N. Dastugue, J. Cools, B. Verhasselt et al., A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias, Leukemia, vol.19, issue.3, pp.358-66, 2005.
DOI : 10.1038/sj.leu.2403657

J. Soulier, E. Clappier, J. Cayuela, A. Regnault, M. García-peydró et al., HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL), Blood, vol.106, issue.1, pp.274-86, 2005.
DOI : 10.1182/blood-2004-10-3900

M. Hatano, C. Roberts, M. Minden, W. Crist, and S. Korsmeyer, Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia, Science, vol.253, issue.5015, pp.79-82, 1991.
DOI : 10.1126/science.1676542

O. Bernard, M. Busson-leconiat, P. Ballerini, M. Mauchauffé, D. Valle et al., A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia, Leukemia, vol.15, issue.10, pp.1495-504, 2001.
DOI : 10.1038/sj.leu.2402249

L. Ellisen, J. Bird, D. West, A. Soreng, T. Reynolds et al., TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms, Cell, vol.66, issue.4, pp.649-61, 1991.
DOI : 10.1016/0092-8674(91)90111-B

L. Brown, J. Cheng, Q. Chen, M. Siciliano, W. Crist et al., Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia, EMBO J, vol.9, pp.3343-51, 1990.

A. Weng, A. Ferrando, W. Lee, J. Morris, L. Silverman et al., Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia, Science, vol.306, issue.5694, pp.269-71, 2004.
DOI : 10.1126/science.1102160

S. Breit, M. Stanulla, T. Flohr, M. Schrappe, W. Ludwig et al., Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia, Blood, vol.108, issue.4, pp.1151-1158, 2006.
DOI : 10.1182/blood-2005-12-4956

M. Dreyling, J. Martinez-climent, M. Zheng, J. Mao, J. Rowley et al., The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family., Proceedings of the National Academy of Sciences, vol.93, issue.10, pp.4804-4813, 1996.
DOI : 10.1073/pnas.93.10.4804

R. Berger, N. Dastugue, M. Busson, J. Van-den-akker, C. Pérot et al., HOX11L2-positive Tcell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hématologique (GFCH) Groupe Français de Cytogénétique Hématologique (GFCH), Leukemia, vol.1417, issue.5, pp.1851-1858, 2003.

C. Graux, J. Cools, C. Melotte, H. Quentmeier, A. Ferrando et al., Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia, Nature Genetics, vol.9, issue.10, pp.1084-1093, 2004.
DOI : 10.1136/jmg.2003.016865

P. Ballerini, A. Blaise, and M. Busson-le-coniat, HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis, Blood, vol.100, issue.3, pp.991-998, 2002.
DOI : 10.1182/blood-2001-11-0093

A. Ferrando, D. Neuberg, J. Staunton, M. Loh, C. Huard et al., Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia, Cancer Cell, vol.1, issue.1, pp.75-87, 2002.
DOI : 10.1016/S1535-6108(02)00018-1

H. Cavé, S. Suciu, C. Preudhomme, B. Poppe, A. Robert et al., Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951, Blood, vol.103, issue.2, pp.442-50, 2004.
DOI : 10.1182/blood-2003-05-1495

M. Van-grotel, J. Meijerink, H. Beverloo, A. Langerak, J. Buys-gladdines et al., The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols, Haematologica, vol.91, pp.1212-1233, 2006.

P. Gaynon, A. Desai, B. Bostrom, R. Hutchinson, B. Lange et al., Early response to therapy and outcome in childhood acute lymphoblastic leukemia, Cancer, vol.86, issue.9, pp.1717-1743, 1997.
DOI : 10.1002/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B

G. Michel, J. Landman-parker, M. Auclerc, C. Mathey, T. Leblanc et al., Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia, Journal of Clinical Oncology, vol.18, issue.7, pp.1517-1541, 2000.
DOI : 10.1200/JCO.2000.18.7.1517

M. Bene, G. Castoldi, W. Knapp, W. Ludwig, E. Matutes et al., Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL), Leukemia, vol.9, pp.1783-1789, 1995.

J. Gabert, E. Beillard, V. Van-der-velden, W. Bi, D. Grimwade et al., Standardization and quality control studies of ???real-time??? quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia ??? A Europe Against Cancer Program, Leukemia, vol.17, issue.12, pp.2318-57, 2003.
DOI : 10.1038/sj.leu.2403135

E. Beillard, N. Pallisgaard, V. Van-der-velden, W. Bi, R. Dee et al., Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ???real-time??? quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) ??? a Europe against cancer program, Leukemia, vol.17, issue.12, pp.2474-86, 2003.
DOI : 10.1038/sj.leu.2403136

V. Asnafi, I. Radford-weiss, N. Dastugue, C. Bayle, D. Leboeuf et al., CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR???? lineage, Blood, vol.102, issue.3, pp.1000-1006, 2003.
DOI : 10.1182/blood-2002-09-2913

X. Su, M. Busson, D. Valle, V. Ballerini, P. Dastugue et al., Various types of rearrangements targetTLX3 locus in T-cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, vol.4, issue.3, pp.243-252, 2004.
DOI : 10.1002/gcc.20088

C. Baldus, T. Burmeister, P. Martus, S. Schwartz, N. Gökbuget et al., Predicts Adverse Outcome in Acute T-Lymphoblastic Leukemia in Adults, Journal of Clinical Oncology, vol.24, issue.29, pp.4714-4734, 2006.
DOI : 10.1200/JCO.2006.06.1580

V. Asnafi, A. Buzyn, X. Thomas, F. Huguet, N. Vey et al., Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study, Blood, vol.105, issue.8, pp.3072-3080, 2005.
DOI : 10.1182/blood-2004-09-3666

C. Logan, R. Wingate, I. Mckay, and A. Lumsden, Tlx-1 and Tlx-3 homeobox gene expression in cranial sensory ganglia and hindbrain of the chick embryo: markers of patterned connectivity, J Neurosci, vol.18, pp.5389-402, 1998.

P. Watt, R. Kumar, and U. Kees, Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemia, Genes, Chromosomes and Cancer, vol.234, issue.4, pp.371-378, 2000.
DOI : 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y

T. Hansen-hagge, M. Schäfer, H. Kiyoi, S. Morris, J. Whitlock et al., Disruption of the RanBP17/Hox11L2 region by recombination with the TCR?? locus in acute lymphoblastic leukemias with t(5;14)(q34;q11), Leukemia, vol.16, issue.11, pp.2205-2217, 2002.
DOI : 10.1038/sj.leu.2402671

R. Hawley, A. Fong, M. Reis, N. Zhang, M. Lu et al., Transforming function of the HOX11/ TCL3 homeobox gene, Cancer Res, vol.57, pp.337-382, 1997.

T. Kawabe, A. Muslin, and S. Korsmeyer, HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint, Nature, vol.385, issue.6615, pp.454-462, 1997.
DOI : 10.1038/385454a0

A. Ferrando, D. Neuberg, R. Dodge, E. Paietta, R. Larson et al., Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia, The Lancet, vol.363, issue.9408, pp.535-541, 2004.
DOI : 10.1016/S0140-6736(04)15542-6

V. Asnafi, K. Beldjord, M. Libura, P. Villarese, C. Millien et al., Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy, Blood, vol.104, issue.13, pp.4173-80, 2004.
DOI : 10.1182/blood-2003-11-3944

M. Schrappe, A. Reiter, M. Zimmermann, J. Harbott, W. Ludwig et al., Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995, Leukemia, vol.14, issue.12, pp.2205-2227, 1981.
DOI : 10.1038/sj.leu.2401973

C. Pui, J. Boyett, G. Rivera, M. Hancock, J. Sandlund et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children???s Research Hospital, Leukemia, vol.14, issue.12, pp.2286-94, 2000.
DOI : 10.1038/sj.leu.2401938

D. Keersmaecker, K. Marynen, P. Cools, and J. , Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia, Haematologica, vol.90, pp.1116-1143, 2005.

J. Bergeron, E. Clappier, I. Radford, A. Buzyn, C. Millien et al., Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs, Blood, vol.110, issue.7, pp.2324-2354, 2007.
DOI : 10.1182/blood-2007-04-079988

M. Dreyling, K. Schrader, C. Fonatsch, B. Schlegelberger, D. Haase et al., MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis, Blood, vol.91, pp.4662-4669, 1998.